SoundHound AI Establishes New Innovation Hub in Bengaluru to Accelerate Global Agentic AI Expansion
SANTA CLARA, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- SoundHound AI, Inc.…
SANY to Unveil New Machines, Smart Technology, and Service at CONEXPO 2026
LAS VEGAS, Feb. 25, 2026 /PRNewswire/ -- SANY will present its most comprehensive…
TERREPOWER Hits New Milestone in Sustainable Manufacturing with a 50 MW Solar Lot
DAPHNE, Ala., Feb. 24, 2026 /PRNewswire/ -- TERREPOWER, formerly BBB Industries, a global…
Only 6% of Marketers Have Fully Implemented AI, According to New Supermetrics Report
HELSINKI, Feb. 24, 2026 /PRNewswire/ -- Supermetrics, the Marketing Intelligence Platform trusted…
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
ROCKVILLE, MD, Feb. 23, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX),…
ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options
Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye…
U.S. Food and Drug Administration (FDA) Accepts Tevas New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-‘749) for the Once-Monthly Treatment of Schizophrenia in Adults
Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the…
LATHAM & WATKINS ELECTS 22 NEW PARTNERS
Promotions from counsel include skilled practitioners advising clients across transactional, litigation, and…
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical…
Coca-Cola India Brings Back Rimzim Jeera with a New Campaign that Refuses to be Subtle
NEW DELHI, Feb. 20, 2026 /PRNewswire/ -- India rediscovers its love for…
